BDI-T 0.24 FIH.U-T 0 MATR-T -0.03 TOU-T -0.5 PPL-T 0.09 ZLU.U-T -0.3
Veru (VERU-Q)

Veru (VERU-Q)

0.00
-0.00 (0.00%)
18 watching
Icon Financials Financials Icon Analysis Technical Analysis
Interactive Chart
1w 1m 6m 1y
0

Related posts

Nervous markets await Nvidia
DON'T BUY

Veru(VERU-Q)

Oct 17, 2022
64% of this company's share floated is shorted, so the market is betting against it.
Jim Cramer - Mad MoneyJim Cramer - Mad Money
Unknown
Unlock Rating
$11.470

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Veru(VERU-Q)

Jan 10, 2022
Their breast cancer treatment just got fast-tracked by the FDA today. And yet, shares fell $5. This makes no sense. This should have risen.
Jim Cramer - Mad MoneyJim Cramer - Mad Money
Unknown
Unlock Rating
$5.340

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Veru(VERU-Q)

Nov 10, 2021
Their prostate cancer drug is real. For $8/share, you're in good shape.
Jim Cramer - Mad MoneyJim Cramer - Mad Money
Unknown
Unlock Rating
$8.370

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Veru(VERU-Q)

Apr 26, 2021
It's come down a lot--too much, but boasts some fine drugs. A crazy trading stock, but he believes in it.
Jim Cramer - Mad MoneyJim Cramer - Mad Money
Unknown
Unlock Rating
$9.430

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Veru(VERU-Q)

Feb 08, 2021
It soared 28% today off great Covid drug data. They've been developing treatments for breast and prostate cancers. A few months ago, the stock tripled on stage 2 clinical trial data for their breast cancer therapy. Earlier this year, they started studying one of their cancer drugs to treat acute respiratory distress caused by severe Covid. This drug showed an 82% in deaths. Phase 3 results will likely come in Q4.
Jim Cramer - Mad MoneyJim Cramer - Mad Money
Unknown
Unlock Rating
$13.920

Stock price when the opinion was issued

biotechnology pharmaceutical
BUY

Veru(VERU-Q)

Dec 14, 2020
It was the biggest gainer in biotech today, this little-known name which soared 52.56% today. This drugmaker focuses on oncology and urology. It's tripled in the past week. They just produced promising phase 2 clinical trial data for their drugs treating breast cancer, and more positive data for prostate cancer. He doesn't chase stocks after a big run, but positive trial data spells a promising stock.
Jim Cramer - Mad MoneyJim Cramer - Mad Money
Unknown
Unlock Rating
$9.695

Stock price when the opinion was issued

biotechnology pharmaceutical
Showing 1 to 6 of 6 entries
  • «
  • ‹
  • 1
  • ›
  • »

Veru(VERU-Q) Rating

Ranking : 1 out of 5

Star iconStar empty iconStar empty iconStar empty iconStar empty icon

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for Veru is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

Veru(VERU-Q) Frequently Asked Questions

What is Veru stock symbol?

Veru is a OTC stock, trading under the symbol VERU-Q on the (). It is usually referred to as or VERU-Q

Is Veru a buy or a sell?

In the last year, there was no coverage of Veru published on Stockchase.

Is Veru a good investment or a top pick?

Veru was never recommended as a Top Pick on Stockchase. Read the latest stock experts ratings for Veru.

Why is Veru stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is Veru worth watching?

0 stock analysts on Stockchase covered Veru In the last year. It is a trending stock that is worth watching.

What is Veru stock price?

On , Veru (VERU-Q) stock closed at a price of $.

Build your watch list

Sign in to track investments
you care about

Latest Buy Signals

GOOG-Q 2.61$181.31
NXPI-Q -4.27$228.92
HII-N 0.07$258.18
KTB-N -2.91$67.6
COF-N -0.95$219.79

Today's Top Picks

BDI-T 0.24$10.79
FIH.U-… 0$18.9
MATR-T -0.03$12.5
TOU-T -0.5$62.27
PPL-T 0.09$50.43

Popular Articles

Latest Sell Signals

CAG-N -0.09$19.4
PLD-N 0.76$109.17
HOOD-Q -0.36$98.34
GE-N 2.85$255.42
SCHW-N -1.07$91.97

Most Recent Experts

Colin Stewart

Colin Stewart

JC Clark Investments Ltd.

Stockchase Insights

Stockchase Insights

5i Research

Jim Cramer - Mad Money

Jim Cramer - Mad Money

CNBC

Bill Harris, CFA

Bill Harris, CFA

Avenue Investment Management

The Panic-Proof Portfolio (Stockchase Research)

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

disclaimer

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at: hello@stockchase.com.

About usHow to useContact Us
More...
AdvertisingIn the newsPrivacy PolicyTerms of service
FacebookX
© Stockchase Inc. by Wealthica